Hjem › Geografisk atrofi › Ohio › Cleveland
Kliniske studier for Geografisk atrofi i Cleveland, OH
6 studier for Geografisk atrofi søker deltakere på steder i og rundt Cleveland (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
RekruttererFase 2/3
- Cleveland Clinic Main Campus, Cleveland
A Phase 1/2 Study of the Safety and Efficacy of BRX011 Oral Administration Once Daily in Subjects With Geographic Atrophy Secondary to Age-Related Macular Degeneration
RekruttererFase 1/2
- Retina Associates of Cleveland, Cleveland
- Retina Associates of Cleveland - Beachwood, Beachwood · 10 mi unna
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
RekruttererFase 3
- University Hospitals Cleveland Medical Center, Cleveland
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
RekruttererFase 2
- Cleveland Clinic Foundation-Cole Eye Institute, Cleveland
Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration
Rekrutterer
- Retina Associates of Cleveland, Beachwood · 10 mi unna
Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD
Rekrutterer
- Cleveland Clinic | Cole Eye Institute, Cleveland
Geografisk atrofi-studier i andre byer
- Dallas, TX8 studier
- Reno, NV8 studier
- Austin, TX7 studier
- Santa Monica, CA7 studier
- Houston, TX6 studier
- The Woodlands, TX6 studier
- Naperville, IL6 studier
- Baltimore, MD6 studier
- Spokane, WA5 studier
- Erie, PA5 studier
- Washington, DC5 studier
- San Antonio, TX5 studier
Andre studier i Cleveland
- Ikke-småcellet lungekreft43 studier
- Kreft (alle typer)36 studier
- Brystkreft35 studier
- Prostatakreft34 studier
- Hjertesvikt33 studier
- Metastatisk kreft30 studier
- Eggstokkreft30 studier
- Lungekreft26 studier
- Kolorektal kreft24 studier
- Kardiovaskulær sykdom22 studier
- Endometriekreft20 studier
- Akut myelogen leukemi20 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.